Researchers find Paxlovid speeds recovery but does not cut hospitalization in vaccinated adults
Updated
Updated · med.ubc.ca · Apr 23
Researchers find Paxlovid speeds recovery but does not cut hospitalization in vaccinated adults
11 articles · Updated · med.ubc.ca · Apr 23
Over 4,200 adults in Canada and the UK participated in two major trials, showing Paxlovid shortened recovery by several days but did not lower hospital admissions or deaths among highly vaccinated, higher-risk groups.
The studies, published in the New England Journal of Medicine, highlight the need to target Paxlovid use and adapt treatment strategies as population immunity evolves, especially with Omicron predominance.
Researchers emphasize that pandemic-era trial infrastructure enables rapid evaluation of therapies, providing a model for future health emergencies and strengthening broader public health systems beyond COVID-19.
Does Paxlovid actually help or harm your chances of getting Long COVID?
Is Paxlovid's faster recovery worth its high cost and common side effects?
Should governments still subsidize Paxlovid for vaccinated COVID-19 patients?
Are we ready for the next pandemic if our best drugs become less effective?
Why do significant gaps in antiviral access and awareness still persist?